SNCA

Seneca Biopharma (SNCA)

Seneca Biopharma Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:SNCA

1 2 3 4 5 6 7 8 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/06/15	07:23	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/06/14	07:45	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/06/14	07:45	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/06/14	07:45	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/06/14	07:44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/06/14	07:44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/06/09	22:39	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/04/28	19:17	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/04/27	19:01	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/04/22	05:52	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/04/22	04:41	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/04/22	04:37	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/04/22	04:35	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/04/06	07:53	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/04/06	07:50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/03/23	06:05	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/03/13	20:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/02/16	06:41	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/02/14	06:35	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/01/25	20:03	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/01/19	20:01	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/01/14	07:11	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/01/05	07:19	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/01/05	01:00	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:SNCA	Seneca Biopharma Inc
2022/12/17	06:52	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNCA	Seneca Biopharma Inc
2022/11/17	01:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNCA	Seneca Biopharma Inc
2022/11/14	22:44	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:SNCA	Seneca Biopharma Inc
2022/10/18	05:33	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNCA	Seneca Biopharma Inc
2022/10/15	05:02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNCA	Seneca Biopharma Inc
2022/10/08	02:31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNCA	Seneca Biopharma Inc